Mary Faris
Inventor
Stats
- 102 US patents issued
- 160 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 102 US Patents Issued
- 160 US Applications Filed
- 868 Total Citation Count
- Feb 13, 2020 Most Recent Filing
- Jul 12, 2000 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
AGENSYS, INC. | 4
24 30 10 17 15 22 15 7 27 15 14 7 4 1 3 1 | 2000
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2017 |
INCYTE CORPORATION | 1
1 1 1 | 2001
2002 2003 2004 |
UROGENESYS, INC. | 1
| 2001
|
INCYTE GENOMICS, INC. | 1
3 | 2000
2001 |
SUMITOMO DAINIPPON PHARMA CO., LTD. | 1
| 2016
|
TOLERO PHARMACEUTICALS, INC. | 2
1 | 2013
2016 |
PHARMACYCLICS LLC | 2
1 1 | 2007
2011 2013 |
MANNKIND CORPORATION | 1
1 2 1 | 2005
2007 2013 2016 |
Inventor Addresses
Address | Duration |
---|---|
LOS ANGELES, CA, US | May 06, 10 - Oct 10, 13 |
Los Angeles, CA | May 09, 02 - Nov 13, 08 |
Los Angeles, CA, US | Aug 29, 02 - Aug 02, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 28 |
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
A61B: | DIAGNOSIS; SURGERY; IDENTIFICATION | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11401347 | 2022 | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins | 0 |
2020/0247,905 | 2020 | ANTIBODIES AND MOLECULES DERIVED THEREFROM THAT BIND TO STEAP-1 PROTEINS | 3 |
10597463 | 2020 | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins | 4 |
2019/0092,874 | 2019 | NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER | 0 |
2018/0179,269 | 2018 | NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.